Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
PerkinElmer
(NY:
PKI
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EDT, May 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about PerkinElmer
< Previous
1
2
3
Next >
PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
June 21, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Launches BioQule NGS System to Automate Library Preparation
June 06, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the First Quarter of 2022
May 03, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Watch for Continued Gains in Shares of PerkinElmer Inc. (PKI)
December 30, 2021
Via
Investor Brand Network
PerkinElmer Board Declares Quarterly Dividend
April 28, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
April 12, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
April 07, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
April 04, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
February 10, 2022
From
PerkinElmer, Inc.
Via
Business Wire
U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
February 03, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
February 01, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Board Declares Quarterly Dividend
January 27, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022
January 11, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference
December 21, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance
December 08, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capability of its RT-PCR Assays
November 29, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021
November 16, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at 2021 Stifel Healthcare Conference
November 05, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the Third Quarter of 2021
November 02, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Releases 2021 Corporate Social Responsibility Report
November 01, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Board Declares Quarterly Dividend
October 27, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis
October 18, 2021
From
PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc.
Via
Business Wire
PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021
October 12, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel
October 07, 2021
From
PerkinElmer, Inc.
Via
Business Wire
EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization
October 05, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend
September 17, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Prices Offering of Senior Notes
September 08, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at 2021 Baird Global Healthcare Conference
August 24, 2021
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the Second Quarter of 2021
July 26, 2021
From
PerkinElmer
Via
Business Wire
PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
July 26, 2021
From
PerkinElmer, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.